{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T14:59:38Z","timestamp":1712069978487},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.jviromet.2007.01.013","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T10:26:22Z","timestamp":1172571982000},"page":"127-135","source":"Crossref","is-referenced-by-count":17,"title":["A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region"],"prefix":"10.1016","volume":"142","author":[{"given":"Jens","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Eis-H\u00fcbinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"D\u00e4umer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta Maria","family":"Rox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hanfland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"P\u00f6tzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2007.01.013_bib1","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1073\/pnas.251194298","article-title":"SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase","volume":"98","author":"Bennett","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2007.01.013_bib2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1089\/0889222041725262","article-title":"Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon","volume":"20","author":"Bodelle","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jviromet.2007.01.013_bib3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1128\/JCM.39.4.1378-1384.2001","article-title":"Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O","volume":"39","author":"de Baar","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2007.01.013_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jviromet.2005.03.013","article-title":"Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma","volume":"127","author":"de Mendoza","year":"2005","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2007.01.013_bib5","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1128\/JCM.39.12.4302-4308.2001","article-title":"TaqMan 5\u2032-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening","volume":"39","author":"Drosten","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2007.01.013_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1373\/clinchem.2006.066498","article-title":"Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5\u2032 long terminal repeat domain","volume":"52","author":"Drosten","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jviromet.2007.01.013_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01713567","article-title":"First case of HIV-1 subtype O infection in Germany","volume":"23","author":"Hampl","year":"1995","journal-title":"Infection"},{"key":"10.1016\/j.jviromet.2007.01.013_bib8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1537-2995.2001.41091100.x","article-title":"A novel RT-PCR for reliable and rapid HCV RNA screening of blood donations","volume":"41","author":"Hennig","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.jviromet.2007.01.013_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-0934(00)00283-4","article-title":"An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques","volume":"92","author":"Holmes","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2007.01.013_bib10","unstructured":"Holmes, H.C., Davis, C.L., Heath, A.B., 2003. Report of an International Collaborative Study to Evaluate a WHO HIV-1 RNA Genotype Reference Panel. WHO Expert Committee on Biological Standardisation. http:\/\/whqlibdoc.who.int\/hq\/2003\/WHO_BS_03.1961.pdf."},{"key":"10.1016\/j.jviromet.2007.01.013_bib11","doi-asserted-by":"crossref","first-page":"35661","DOI":"10.1074\/jbc.C000447200","article-title":"Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity","volume":"275","author":"Imai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jviromet.2007.01.013_bib12","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1091\/mbc.E05-01-0084","article-title":"Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy","volume":"16","author":"James","year":"2005","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.jviromet.2007.01.013_bib13","first-page":"333","article-title":"Molecular epidemiology of HIV","volume":"121","author":"Kandathil","year":"2005","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jviromet.2007.01.013_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1515\/CCLM.2005.139","article-title":"Development, validation and evaluation of a homogenous one-step reverse transcriptase-initiated PCR Assay with competitive internal control for the detection of hepatitis C virus RNA","volume":"43","author":"Mueller","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jviromet.2007.01.013_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1373\/clinchem.2003.024281","article-title":"Quantitative tissue factor gene expression analysis in whole blood: development and evaluation of a real-time PCR platform","volume":"50","author":"Mueller","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jviromet.2007.01.013_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2807\/esm.10.02.00522-en","article-title":"Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000\u20132002: risk of virus transmission and the impact of nucleic acid amplification testing","volume":"10","author":"Offergeld","year":"2005","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jviromet.2007.01.013_bib17","unstructured":"Paul-Ehrlich-Institut: Bundesamt f\u00fcr Sera und Impfstoffe, 2003. Bekanntmachung \u00fcber die Zulassung und Registrierung von Arzneimitteln: Verminderung des Risikos von HIV-Infektionen durch zellul\u00e4re Blutprodukte und gefrorenes Frischplasma\u2014Anordnung der Testung auf HIV-1-RNA mit Nukleins\u00e4ure-Amplifikationstechniken. Bundesanzeiger. 103, 12269."},{"key":"10.1016\/j.jviromet.2007.01.013_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00126334-200305010-00001","article-title":"Plasma RNA quantification and HIV-1 divergent strains","volume":"33","author":"Plantier","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jviromet.2007.01.013_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1423-0410.2004.00529.x","article-title":"First human immunodeficiency virus-1 group O infection in a European blood donor","volume":"87","author":"Rox","year":"2004","journal-title":"Vox. Sang."},{"key":"10.1016\/j.jviromet.2007.01.013_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1386-6532(00)00149-9","article-title":"Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products","volume":"20","author":"Saldanha","year":"2001","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2007.01.013_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1086\/315254","article-title":"Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States","volume":"181","author":"Sullivan","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2007.01.013_bib22","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1128\/JCM.43.8.3860-3868.2005","article-title":"Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT","volume":"43","author":"Swanson","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2007.01.013_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jviromet.2006.06.010","article-title":"Performance of the automated Abbott RealTimetrade mark HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx((R)) HIV RNA Quantitative assays","volume":"137","author":"Swanson","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2007.01.013_bib24","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1537-2995.2002.00183.x","article-title":"NAT screening of blood and plasma donations: evolution of technology and regulatory policy","volume":"42","author":"Tabor","year":"2002","journal-title":"Transfusion"},{"issue":"Suppl.","key":"10.1016\/j.jviromet.2007.01.013_bib25","first-page":"26","article-title":"HIV update. Diagnostic tests and markers of disease progression and response to therapy","volume":"18","author":"Zhang","year":"2002","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093407000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093407000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T19:37:09Z","timestamp":1556134629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093407000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0166093407000420"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2007.01.013","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}